Foundry Partners, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2021$2,090,000
-4.2%
62,225
-16.1%
0.08%0.0%
Q2 2021$2,181,000
-4.4%
74,170
-16.2%
0.08%0.0%
Q1 2021$2,281,000
+8.7%
88,495
-3.8%
0.08%
-8.5%
Q4 2020$2,098,000
+11.5%
92,015
+4.5%
0.08%
-9.9%
Q3 2020$1,882,000
+9.6%
88,025
+19.0%
0.09%
+8.3%
Q2 2020$1,717,00073,9900.08%
Other shareholders
IRADIMED CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders